Project Grant R03TR006113
Award Date
8/1/25
Completion Date
7/31/26
Dollars Obligated
$178K
Federal Agency
National Center for Advancing Translational Sciences
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), is supporting research at the University of California, San Francisco (UCSF) to investigate the regulation of transcription and activity of the calcium transporter SLC24A4 in enamel formation. The $451,000 award aims to determine the molecular mechanisms underlying the upregulation of SLC24A4 transcription in maturation...
This Project Grant award from the National Center for Advancing Translational Sciences (CFDA 93.350) provides $176,500.00 to the University of Washington for the period of July 1, 2024 to June 30, 2025. The goal of the project is to delineate the pathogenic effects of ATP2C1 loss-of-function in human keratinocytes and organotypic epidermis to identify therapeutic strategies for Hailey-Hailey Disease (HHD), a rare skin blistering disorder. The research aims to determine how SPCA1 deficiency...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $445,000.00 to The Children's Hospital of Philadelphia (CHOP) to develop technologies for delineating haplotype-resolved, full-length transcriptomes in bulk tissues and single cells. The project aims to characterize transcript isoforms of haploinsufficient genes to discover novel therapeutic targets, as well as establish a program for...
This federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research provides $419,204 to The University of Kentucky Research Foundation to conduct research on rare genetic disorders associated with the SHOC2 gene. The project aims to use a zebrafish model to functionally characterize genetic variants found in patients with Noonan Syndrome with Loose Anagen Hair...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $407,770 Project Grant (CFDA # 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The grant supports an exploratory study on the role of NKG2D signaling in T cell trafficking and its implications for vitiligo and melanoma. The study aims to define the underlying signaling pathways through which...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) aims to advance the treatment and molecular understanding of oculocutaneous albinism (OCA) through gene therapy. The $103,860 award to the University of Pittsburgh will fund research to: Identify the optimal therapeutic window and delivery route for an adeno-associated viral vector gene therapy targeting the TYR gene, which is mutated in OCA1. Evaluate the ability of the TYR gene therapy to rescue...
This Project Grant award from the National Center for Advancing Translational Sciences (NCATS), under the CFDA Program 93.350 - National Center for Advancing Translational Sciences, will provide $148,248 to Michigan State University to conduct research aimed at screening variants of the manganese transporter SLC39A8 to identify pathogenic variants. The primary objectives are to: 1) Develop and apply a high-throughput cell-based transport assay to screen nearly 300 SLC39A8 variants for impaired...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded a $130,680 Project Grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) for the period of July 1, 2025 to June 30, 2027. The grant will fund the development of robust computational technologies for single-cell functional genomics, enabling the comprehensive identification of genetic variants (SNPs) that regulate tissue niches...
This Project Grant award under the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) will provide $410,000.00 to The University of Texas Southwestern Medical Center to conduct research on the regulation of the phosphate transporter SLC20A1. The research aims to examine the mechanisms governing SLC20A1 internalization, degradation, recycling, and synthesis in order to better understand phosphate sensing and homeostasis in...
This federal Project Grant award of $126,830 from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports research to develop a somatic mutation-resolved lineage tracing system. The project aims to reconstruct single-cell genealogical trees and detect associated somatic mutations and epigenetic alterations. This will enable investigations into the impact of genomic modifications on the evolutionary dynamics of hematopoietic stem cells, including during...